Dicentra Inc.   Report issue

For profit Phase 2
Founded: Toronto Canada (2002)

Organization Overview

First Clinical Trial
2010
NCT01176227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dicentra Inc.